Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities
Stijn Bekkers1, Corinne P Delsing2, Saskia E Kok2
1From the Department of Otorhinolaryngology and Head and Neck Surgery (S.B., C.P.D., S.E.K., A.R.T.S., F.J.A.v.d.H.), Radboud University Medical Centre, Nijmegen; and Departments of Rehabilitation (K.v.H.) and Paediatric Neurology (C.E.E.), Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands. Stijn.Bekkers@radboudumc.nl.
Submandibular duct ligation (2-DL) is more effective than botulinum neurotoxin type A (BoNT-A) for treating drooling in children with neurodevelopmental disabilities. 2-DL showed superior results at 32 weeks, though with a slightly higher risk of complications.
Area of Science:
- Pediatric Otolaryngology
- Neurodevelopmental Disabilities
- Sialorrhea Management
Background:
- Excessive drooling (sialorrhea) is a common challenge in children and adolescents with neurodevelopmental disabilities.
- Current treatments aim to reduce saliva production and improve quality of life.
- Comparing surgical and pharmacological interventions is crucial for optimizing care.
Purpose of the Study:
- To compare the efficacy and safety of submandibular duct ligation (2-DL) versus submandibular botulinum neurotoxin type A (BoNT-A) injections for treating drooling.
- To evaluate outcomes using standardized measures of drooling severity and frequency.
Main Methods:
- A randomized, controlled, partly single-blinded study involving 53 pediatric patients with neurodevelopmental disabilities and excessive drooling.
- Patients were randomized to receive either 2-DL or a one-time intraglandular BoNT-A injection.
- Outcomes assessed included Visual Analog Scale (VAS), drooling quotient (DQ), drooling severity (DS), and drooling frequency (DF) at baseline, 8, and 32 weeks post-treatment.
Main Results:
- Submandibular duct ligation (2-DL) demonstrated significantly higher treatment response rates (63.0% vs 26.9%, p=0.008) at 32 weeks compared to BoNT-A.
- Both VAS scores and DQ were significantly reduced post-2-DL compared to BoNT-A (p<0.001 and p=0.022, respectively).
- Adverse events and postoperative complaints were more frequent and prolonged following 2-DL than BoNT-A.
Conclusions:
- Submandibular duct ligation (2-DL) is a more effective treatment for reducing drooling in children with neurodevelopmental disabilities compared to a single BoNT-A injection.
- While 2-DL offers superior efficacy, it is associated with a slightly higher risk of complications and morbidity.
- This study provides Class III evidence supporting 2-DL as a more effective long-term solution for severe drooling in this population.
More Related Videos
Related Concept Videos
Clinical Trials: Overview
Trial and Error and Algorithm
Clinical Trials
There are four phases in a clinical trial. A phase one...
Random Error
Random Variables
Uppercase letters such as X or Y denote a random variable. Lowercase letters like x or y denote the value of a random variable. If X is a random variable, then X is written in words, and x is given as a number.
For example, let X = the...
Randomized Experiments
Simple randomization
Simple...

